NASA’s Mars Sample Return program faces opposition from planetary scientists following proposed cancellation, with concerns raised over Perseverance samples, future Mars missions, and international ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

The United States military has quietly locked in a sweeping artificial intelligence partnership with Elon Musk's startup xAI, ...

In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and ...

Mars Sample Return is stalled as costs rise while China’s Tianwen-3 targets a 2031 return. Learn why this matters for science ...

The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

ATRIMED today shared an update on a long running research effort led in part by physician scientist Dr. Latha Damle, whose ...

But some of it comes to the United States. It is not an accident that the E.L.N., the guerrilla group that’s heavily engaged ...

The integration of flexible manufacturing, process intensification, and sustainability is redefining the global supply chain.

The partnership will enable kdc/one to accelerate R&D lifecycle & leverage innovation expertise with Potion AI’s models & ...

AI prioritizes clinical trials by identifying unmet medical needs, optimizing resource allocation, and focusing on conditions ...